These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32594806)

  • 1. Association Between the European Society of Cardiology/European Society of Hypertension Heart Rate Thresholds for Cardiovascular Risk and Neuroadrenergic Markers.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Facchetti R; Mancia G
    Hypertension; 2020 Aug; 76(2):577-582. PubMed ID: 32594806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome.
    Seravalle G; Vanoli J; Molisano C; Merati V; Grassi G
    Acta Diabetol; 2022 Nov; 59(11):1429-1435. PubMed ID: 35904642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome.
    Quarti Trevano F; Seravalle G; Macchiarulo M; Villa P; Valena C; Dell'Oro R; Mancia G; Grassi G
    J Hypertens; 2017 Aug; 35(8):1685-1690. PubMed ID: 28350577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease.
    Grassi G; Fowler B; Scali B; Rossi F; Motto E; Pieruzzi F; Mancia G
    J Hypertens; 2022 Aug; 40(8):1530-1536. PubMed ID: 35792492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension.
    Dell'Oro R; Quarti-Trevano F; Seravalle G; Zanchettin F; Bertoli S; Airoldi F; Mancia G; Grassi G
    Hypertension; 2019 Oct; 74(4):903-909. PubMed ID: 31378103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate as marker of sympathetic activity.
    Grassi G; Vailati S; Bertinieri G; Seravalle G; Stella ML; Dell'Oro R; Mancia G
    J Hypertens; 1998 Nov; 16(11):1635-9. PubMed ID: 9856364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic Overactivation in Patients With Essential Hypertension and Hepatic Iron Overload.
    Seravalle G; Dell'Oro R; Quarti-Trevano F; Spaziani D; Bertoli S; Airoldi F; Mancia G; Grassi G
    Hypertension; 2020 Nov; 76(5):1444-1450. PubMed ID: 32981363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction.
    Seravalle G; Quarti-Trevano F; Dell'Oro R; Gronda E; Spaziani D; Facchetti R; Cuspidi C; Mancia G; Grassi G
    J Hypertens; 2019 Feb; 37(2):443-448. PubMed ID: 30020242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early sympathetic activation in the initial clinical stages of chronic renal failure.
    Grassi G; Quarti-Trevano F; Seravalle G; Arenare F; Volpe M; Furiani S; Dell'Oro R; Mancia G
    Hypertension; 2011 Apr; 57(4):846-51. PubMed ID: 21300663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Dubini A; Mancia G
    Metabolism; 2009 Oct; 58(10):1446-51. PubMed ID: 19515393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behaviour of regional adrenergic outflow in mild-to-moderate renal failure.
    Grassi G; Seravalle G; Arenare F; Buccianti G; Furiani S; Ilardo V; Bolla G; Mancia G
    J Hypertens; 2009 Mar; 27(3):562-6. PubMed ID: 19330916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure.
    Grassi G; Seravalle G; Vanoli J; Facchetti R; Spaziani D; Mancia G
    Clin Res Cardiol; 2023 Jan; 112(1):59-67. PubMed ID: 35552503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited reliability of heart rate as a sympathetic marker in chronic kidney disease.
    Dell'Oro R; Quarti-Trevano F; Seravalle G; Bertoli S; Lovati C; Mancia G; Grassi G
    J Hypertens; 2021 Jul; 39(7):1429-1434. PubMed ID: 33394867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated heart rate as sympathetic biomarker in human obesity.
    Seravalle G; Facchetti R; Cappellini C; Annaloro A; Gelfi E; Grassi G
    Nutr Metab Cardiovasc Dis; 2022 Oct; 32(10):2367-2374. PubMed ID: 35970685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction.
    Grassi G; Seravalle G; Quarti-Trevano F; Dell'Oro R; Arenare F; Spaziani D; Mancia G
    Hypertension; 2009 Feb; 53(2):205-9. PubMed ID: 19124679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension.
    Grassi G; Seravalle G; Brambilla G; Pini C; Alimento M; Facchetti R; Spaziani D; Cuspidi C; Mancia G
    Int J Cardiol; 2014 Dec; 177(3):1020-5. PubMed ID: 25449517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate as a sympathetic marker during acute adrenergic challenge.
    Grassi G; Seravalle G; Bolla G; Quarti-Trevano F; Dell'Oro R; Arenare F; Mancia G
    J Hypertens; 2008 Jan; 26(1):70-5. PubMed ID: 18090542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic and baroreflex function in hypertensive or heart failure patients with ventricular arrhythmias.
    Grassi G; Seravalle G; Dell'Oro R; Facchini A; Ilardo V; Mancia G
    J Hypertens; 2004 Sep; 22(9):1747-53. PubMed ID: 15311103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension.
    Grassi G; Turri C; Dell'Oro R; Stella ML; Bolla GB; Mancia G
    J Hypertens; 1998 Dec; 16(12 Pt 1):1789-96. PubMed ID: 9869013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives.
    Grassi G
    Hypertension; 2009 Oct; 54(4):690-7. PubMed ID: 19720958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.